A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult Volunteers

NCT05954247 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers

NCT04159961 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

NCT03016520 ·Status: UNKNOWN ·Phase: PHASE1

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

NCT05149274 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

NCT06147908 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

NCT04167267 ·Status: UNKNOWN ·Phase: PHASE1

PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers

NCT07256600 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers

NCT06119945 ·Status: RECRUITING ·Phase: PHASE1

Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers

NCT06318845 ·Status: COMPLETED ·Phase: PHASE1

Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315

NCT06592495 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult Volunteers

NCT05954338 ·Status: UNKNOWN ·Phase: PHASE1

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

NCT05823883 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult Volunteers

NCT06109259 ·Status: RECRUITING ·Phase: PHASE1

Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects

NCT02952547 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

NCT03016494 ·Status: UNKNOWN ·Phase: PHASE1

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

NCT05192395 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

NCT05739851 ·Status: UNKNOWN ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State

NCT05739916 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

NCT05214690 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

NCT05023031 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

NCT07239453 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers

NCT06010589 ·Status: UNKNOWN ·Phase: PHASE1

To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy Volunteers

NCT05463497 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402

NCT02897726 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

NCT06616883 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1